Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Other Non Operating Income (2017 - 2025)

Selectis Health's Other Non Operating Income history spans 11 years, with the latest figure at $595102.0 for Q3 2025.

  • For Q3 2025, Other Non Operating Income rose 1396.32% year-over-year to $595102.0; the TTM value through Sep 2025 reached $821813.0, up 103.64%, while the annual FY2024 figure was $239981.0, 19.05% down from the prior year.
  • Other Non Operating Income for Q3 2025 was $595102.0 at Selectis Health, up from $41753.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $595102.0 in Q3 2025 and bottomed at -$614556.0 in Q4 2021.
  • The 5-year median for Other Non Operating Income is $41753.0 (2025), against an average of $82486.4.
  • The largest annual shift saw Other Non Operating Income tumbled 407.98% in 2024 before it skyrocketed 1396.32% in 2025.
  • A 5-year view of Other Non Operating Income shows it stood at -$614556.0 in 2021, then soared by 106.57% to $40365.0 in 2022, then decreased by 0.67% to $40095.0 in 2023, then crashed by 407.98% to -$123486.0 in 2024, then surged by 581.92% to $595102.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Other Non Operating Income are $595102.0 (Q3 2025), $41753.0 (Q2 2025), and $308444.0 (Q1 2025).